IM8 Surpasses Key Milestone as Parent Company Prenetics Reports Record Growth

August 18, 2026 - In a landmark moment for consumer health company IM8, parent company Prenetics announced that its flagship brand has surpassed a key milestone in its financial performance. Speaking at the company's first-ever live earnings video webcast, CEO [Name] revealed that IM8 has finally crossed the line where growth stops consuming cash and starts producing it.

In a remarkable turnaround, IM8's consolidated adjusted free cash flow turned positive for the first time in history last month, marking a significant achievement for the company. As Prenetics' CEO explained, this milestone was always the ultimate goal for the business, with every decision made by the company since its inception aimed at reaching this point.

With 20 months of data to draw on, IM8 has demonstrated remarkable growth, from its initial $400,000 in sales during its first month on the market to a staggering $1 billion in revenue. This achievement is all the more impressive given the company's ambitious plan to invest in marketing and brand development through a recent $1 billion growth financing.

At the heart of IM8's success lies its commitment to delivering the best possible product, with a comprehensive 92-ingredient sachet that offers customers a convenient and effective way to achieve optimal nutrition. As one satisfied customer put it, "IM8 is an amazing product that really works."

Prenetics' CEO was keen to emphasize the company's dedication to transparency, releasing a detailed shareholder letter and investor deck that provide unprecedented insights into the business. The company's commitment to openness extends to its live earnings webcast, where attendees were encouraged to ask questions directly.

For IM8 and Prenetics, this milestone marks an exciting new chapter in the company's journey. With its sights set on continued growth and innovation, the brand is poised to make a significant impact in the consumer health sector.